title: Randomized trials to optimize treatment of multidrug-resistant tuberculosis.
authors.affiliation: Harvard Medical School, Boston, Massachusetts, United States of America. carole_mitnick@hms.harvard.edu
authors.forename: Carole D
authors.initials: CD
authors.lastname: Mitnick
authors.forename: Kenneth G
authors.initials: KG
authors.lastname: Castro
authors.forename: Mark
authors.initials: M
authors.lastname: Harrington
authors.forename: Leonard V
authors.initials: LV
authors.lastname: Sacks
authors.forename: William
authors.initials: W
authors.lastname: Burman
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy* / Q000382:microbiology; D024841:Fluoroquinolones / Q000627:therapeutic use; D006801:Humans; D009169:Mycobacterium tuberculosis; D016032:Randomized Controlled Trials as Topic; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D024841:Fluoroquinolones